FDA vaccine advisers reject Pfizer's booster request:
Vaccine advisers to the US Food and Drug Administration rejected Pfizer’s application to add a third, booster dose of its coronavirus vaccine to the two-dose regimen.Members of the FDA’s Vaccines and Related Biological Products Advisory Committee rejected the application by a vote of 16 to 2. But they reserved the right to amend the question being asked in a second round of voting.
The voting question: Do the safety and effectiveness data from clinical trial C4591001 support approval of a COMIRNATY booster dose administered at least six months after completion of the primary series for use in individuals 16 years of age and older?
Coronavirus update: FDA booster meeting and Covid-19 vaccine news
The Food and Drug Administration's advisory committee is meeting today to discuss booster doses of coronavirus vaccine. Follow here for the latest news.